Acute kidney injury: diagnosis, staging and prevention
Prevention and early recognition of acute kidney injury can improve outcomes for those affected. Pharmacists can help to review patients whose renal function is at risk of rapid deterioration
Around 20% of patients who are admitted to hospital acutely will develop acute kidney injury (AKI). The term describes a rapid deterioration in renal function and is characterised by reduced urine output and increased serum creatinine. The cause of AKI can be pre-renal (eg, hypovolaemia), intrinsic (eg, acute interstitial nephritis) or post-renal (eg, urinary obstruction).
AKI is largely preventable and pharmacists should take steps to optimise medicines for patients at high risk of the condition. This can involve providing advice about avoiding potentially nephrotoxic medicines, monitoring renal function and reviewing medicines.
Sue Shaw is renal pharmacist and Nick Selby is consultant nephrologist, both at Royal Derby Hospital. Adrian Coleman is renal pharmacist at Kent and Canterbury Hospital.
E: [email protected]
Citation: Clinical Pharmacist URI: 11098637
Recommended from Pharmaceutical Press
All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.£27.00
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.£38.00
An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.£54.00
This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.£27.00